Growth pattern of tumours in mice induced by murine Moloney sarcoma-virus and sarcoma-virus-transformed cells
Open Access
- 1 December 1979
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 40 (6), 932-942
- https://doi.org/10.1038/bjc.1979.288
Abstract
Transplantation of a Moloney sarcoma-virus (MSV-M)-transformed producer cell line (Sac(+)) induced progressively or regressively growing tumours in mice. Progressive growth always occurred after transplantation of an MSV-M non-producer transformant (Sac(-)), whereas the MSV-M released from the producer cells (Sac virus) always induced tumours which regressed. In contrast to the non-producer, the producer transformant Sac(+) as well as Sac virus induced a strong immune response, detected in vitro by cell- and antibody-mediated cytotoxicity assays, and in vivo by transplantation immunity. Implantation of Sac(-) cells led to solid, under-vascularized tumours, consisting histologically of uniform densely packed tumour cells. Sac-virus-induced tumours, however, were very well vascularized and arose by proliferation of different connective-tissue cells. After transplantation of Sac(+) cells, tumours were found to consist of typical tumour cells morphologically similar to Sac(-) cells intermingled with proliferated connective-tissue cells. Cultivation of tumour fragments from Sac(+) and Sac(-) tumours was followed by outgrowth of transformed tumour cells with the properties of the originally implanted cells. Tumour explant cultures from Sac-virus-induced tumours did not lead to growth of stably transformed cells. Co-culture of mouse embryo fibroblasts (MEF) with Sac(+) cells resulted in overgrowth of the transformed cells. Infection of MEF with Sac virus led to transiently transformed cells. It is concluded that Sac(+) cell tumours will resist the strong immune defence mechanisms they induce and grow progressively, if the inoculated cells are able to build up a solid, poorly vascularized nodule in the tissue. This always happens after implantation of 10(6) cells, but only occasionally when fewer cells are inoculated. Sac-virus-induced tumours will always regress owing to the strong immune response. The regression is furthered by the fact that MSV-M infection rarely if ever leads to a stable transformation.This publication has 30 references indexed in Scilit:
- Viral ‘tumor antigens’ a novel type of mammalian regulator proteinBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1978
- Generation of New Mouse Sarcoma Viruses in Cell CultureScience, 1978
- Nonproducer malignant tumor cells with rescuable sarcoma virus genome isolated from a recurrent Moloney sarcoma.The Journal of Experimental Medicine, 1978
- Immunogenicity of tumor antigensBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1977
- Increased ornithine decarboxylase activity in murine sarcoma virus infected cellsNature, 1976
- Delayed tumour appearance and absence of regression in nude mice infected with murine sarcoma virusNature, 1975
- Murine Sarcoma Virus: The Question of DefectivenessScience, 1970
- THE BEHAVIOUR OF TWO STRAINS OF MURINE SARCOMA VIRUS IN VITROAustralian Journal of Experimental Biology and Medical Science, 1970
- Transformation of Hamster Cell Lines in vitro by a Hamster Sarcoma VirusNature, 1970
- Studies on murine sarcoma virus; A morphological comparison of tumorigenesis by the harvey and moloney strains in mice, and the establishment of tumor cell linesInternational Journal of Cancer, 1969